These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 7594950)
1. [Therapy of obesity using appetite depressants]. Ikeda Y Nihon Naika Gakkai Zasshi; 1995 Aug; 84(8):1290-4. PubMed ID: 7594950 [No Abstract] [Full Text] [Related]
2. [Mazindol, an anorectic of a new series, in the treatment of obesity (author's transl)]. Dolecek R Cas Lek Cesk; 1975 Feb; 114(8):249-54. PubMed ID: 1095197 [No Abstract] [Full Text] [Related]
3. [Mazindol]. Mori Y Nihon Rinsho; 2011 Jan; 69 Suppl 1():683-6. PubMed ID: 21766681 [No Abstract] [Full Text] [Related]
4. [Long-term treatment of patients with obesity using mazindol and a reducing diet]. van Seters AP; Bouwhuis-Hoogerwerf ML; Goslings BM; van Nieuwkoop L; van Slooten H; Struijk-Wielinga T Ned Tijdschr Geneeskd; 1982 May; 126(22):990-4. PubMed ID: 7110390 [No Abstract] [Full Text] [Related]
5. Mazindol (Teronac)- another anorectic drug. Drug Ther Bull; 1974 Dec; 12(26):101-2. PubMed ID: 4459058 [No Abstract] [Full Text] [Related]
6. Three controlled trials of weight loss with phenylpropanolamine. Altschuler S; Conte A; Sebok M; Marlin RL; Winick C Int J Obes; 1982; 6(6):549-56. PubMed ID: 6761288 [TBL] [Abstract][Full Text] [Related]
8. A double blind controlled trial of a new anorectic agent AN448. Woodhouse SP; Nye ER; Anderson K; Rawlings J N Z Med J; 1975 Jun; 81(542):546-9. PubMed ID: 1099491 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of the anorectic effect of mazindol and placebo in obesity]. Tatoń J; Czech A; Koliński P; Podwysocka G Pol Tyg Lek; 1979 Dec; 34(50):1967-70. PubMed ID: 395517 [No Abstract] [Full Text] [Related]
10. [Anorexiant drugs in the ambulant treatment of obese patients (author's transl)]. Jenny S; Zimmermann KG; Radielovic P; Bühlmann AA Schweiz Rundsch Med Prax; 1976 Jul; 65(28):874-8. PubMed ID: 1005298 [No Abstract] [Full Text] [Related]
11. [Drug treatment of obesity]. Meinders AE; Toornvliet AC; Pijl H Ned Tijdschr Geneeskd; 1996 Aug; 140(32):1632-4. PubMed ID: 8815403 [No Abstract] [Full Text] [Related]
12. [Treatment of obesity in general practice with femoxetine. A controlled clinical trial of the effects of femoxetine and placebo]. Kristensen JS; Christiansen P; Skrumsager BK Ugeskr Laeger; 1982 Mar; 144(13):939-42. PubMed ID: 7048680 [No Abstract] [Full Text] [Related]
17. Preliminary clinical evaluation of a new appetite suppressant. A double-blind study. Feldman HS J Med Soc N J; 1966 Oct; 63(10):454-7. PubMed ID: 5341753 [No Abstract] [Full Text] [Related]
18. Double-blind trial of anorectic agents. Bell DS Med J Aust; 1969 Mar; 1(11):599-600. PubMed ID: 4889482 [No Abstract] [Full Text] [Related]
19. [Appetite depressants: do they carry any weight?]. Cluysenaer OJ; Tjoeng MM Ned Tijdschr Geneeskd; 1987 Mar; 131(10):388-91. PubMed ID: 3561533 [No Abstract] [Full Text] [Related]
20. Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity. Defelice EA; Chaykin LB; Cohen A Curr Ther Res Clin Exp; 1973 Jul; 15(7):358-66. PubMed ID: 4198296 [No Abstract] [Full Text] [Related] [Next] [New Search]